Skip to main content

XTX Topco Ltd

SEC CIK
0001828301
Latest filing
Aug 14, 2026

FATE holding history

Fate Therapeutics Inc in every 13F filed by XTX Topco Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

FATE overviewAll 13F holders of FATEFull Q2 2026 holdings

Shares (Q2 2026)
180,826
Value
$488.2K
% of portfolio
<0.1%
Quarters held
15
Since Q2 2021
Holdings of FATE by XTX Topco Ltd, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026180,826$488.2K<0.1%−208,343−53.5%ReducedHolders
Q1 2026389,169$467.0K<0.1%+24,431+6.7%AddedHolders
Q4 2025364,738$358.4K<0.1%−73,180−16.7%ReducedHolders
Q3 2025437,918$551.8K<0.1%+5,590+1.3%AddedHolders
Q2 2025432,328$484.2K<0.1%−26,980−5.9%ReducedHolders
Q1 2025459,308$362.9K<0.1%+209,508+83.9%AddedHolders
Q4 2024249,800$412.2K<0.1%+249,800NewHolders
Q3 20240$00.0%−33,898−100.0%Sold outHolders
Q2 202433,898$111.2K<0.1%+16,510+95.0%AddedHolders
Q1 202417,388$127.6K<0.1%+17,388NewHolders
Q4 20230$00.0%−192,920−100.0%Sold outHolders
Q3 2023192,920$409.0K0.1%+171,321+793.2%AddedHolders
Q2 202321,599$102.8K<0.1%−6,591−23.4%ReducedHolders
Q1 202328,190$160.7K<0.1%−76,000−72.9%ReducedHolders
Q4 2022104,190$1.05M0.2%+83,670+407.7%AddedHolders
Q3 202220,520$460.0K0.1%+20,520NewHolders
Q3 20210$00.0%−5,039−100.0%Sold outHolders
Q2 20215,039$437.0K0.1%+5,039NewHolders